Next, focusing on data from the entire cohort of patients with breast cancer, we found that high coexpression of IL-31Ra, IL-4, IL-2, and Granzyme B was associated with increased survival, with results almost reaching statistical significance (p=0.056; online supplementary figure S7B). Here, IL2 is linked to breast carcinoma.